Progression of dopamine transporter decline in patients with the Parkinson variant of multiple system atrophy: A voxel-based analysis of [ 123I]β-CIT SPECT

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 39, Issue 6, 2012, Pages 1012-1020

  Nocker, Michael ^a   Seppi, Klaus ^a   Donnemiller, Eveline ^a   Virgolini, Irene ^a   Wenning, Gregor K ^a   Poewe, Werner ^a   Scherfler, Christoph ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Dopamine transporter; Multiple system atrophy; Parkinson disease; SPECT; Voxel by voxel analysis

Indexed keywords

DOPAMINE TRANSPORTER; IOMETOPANE I 123;

ADULT; AGED; ANTERIOR PUTAMEN; ARTICLE; BRAIN STEM; CAUDATE NUCLEUS; CLINICAL ARTICLE; CORPUS STRIATUM; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; MALE; MESENCEPHALON; PARKINSON DISEASE; PARKINSON VARIANT MULTIPLE SYSTEM ATROPHY; PONS; PUTAMEN; SHY DRAGER SYNDROME; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; UNIFIED PARKINSON DISEASE RATING SCALE;

BRAIN; COCAINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MOTOR ACTIVITY; MULTIPLE SYSTEM ATROPHY; PARKINSON DISEASE; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84862644656     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-012-2100-5     Document Type: Article

References (48)

1. PL Lantos 1998 The definition of multiple system atrophy: a review of recent developments J Neuropathol Exp Neurol 57 1099 1111 9862632 10.1097/00005072-199812000-00001 1:STN:280:DyaK1M%2FnslClug%3D%3D
2. GK Wenning F Tison Y Ben Shlomo SE Daniel NP Quinn 1997 Multiple system atrophy: a review of 203 pathologically proven cases Mov Disord 12 133 147 9087971 10.1002/mds.870120203 1:STN:280:DyaK2s3kt12qsw%3D%3D
3. GK Wenning Y Ben Shlomo M Magalhães SE Daniel NP Quinn 1994 Clinical features and natural history of multiple system atrophy. An analysis of 100 cases Brain 117 Pt 4 835 845 7922469 10.1093/brain/117.4.835
4. H Watanabe Y Saito S Terao T Ando T Kachi E Mukai, et al. 2002 Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients Brain 125 1070 1083 11960896 10.1093/brain/awf117
5. Y Ben-Shlomo GK Wenning F Tison NP Quinn 1997 Survival of patients with pathologically proven multiple system atrophy: a meta-analysis Neurology 48 384 393 9040727 1:STN:280:DyaK2s7ptlWgtw%3D%3D
6. JP Seibyl KL Marek D Quinlan K Sheff S Zoghbi Y Zea-Ponce, et al. 1995 Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease Ann Neurol 38 589 598 7574455 10.1002/ana.410380407 1:STN:280:DyaK28%2FgtFaitw%3D%3D
7. T Brucke S Asenbaum W Pirker S Djamshidian S Wenger C Wober, et al. 1997 Measurement of the dopaminergic degeneration in Parkinson's disease with [123I]beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy J Neural Transm Suppl 50 9 24 9120429 1:STN:280:DyaK2s7ptFKrsw%3D%3D
8. K Marek R Innis C van Dyck B Fussell M Early S Eberly, et al. 2001 [123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression Neurology 57 2089 2094 11739831 1:STN:280:DC%2BD3MjgtFCrsA%3D%3D
9. A Varrone KL Marek D Jennings RB Innis JP Seibyl 2001 [(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy Mov Disord 16 1023 1032 11748733 10.1002/mds.1256 1:STN:280:DC%2BD3MnpvFCisA%3D%3D
10. GM Knudsen M Karlsborg G Thomsen K Krabbe L Regeur T Nygaard, et al. 2004 Imaging of dopamine transporters and D2 receptors in patients with Parkinson's disease and multiple system atrophy Eur J Nucl Med Mol Imaging 31 1631 1638 15583914 10.1007/s00259-004-1578-x 1:CAS:528:DC%2BD2cXhtVCmurrN
11. C Scherfler K Seppi E Donnemiller G Goebel C Brenneis I Virgolini, et al. 2005 Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease Brain 128 1605 1612 15817519 10.1093/brain/awh485
12. MM Hoehn MD Yahr 1967 Parkinsonism: onset, progression and mortality Neurology 17 427 442 6067254 1:STN:280:DyaF2s7jvFSgsg%3D%3D
13. Fahn S, Elton R. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, editors. Recent developments in Parkinson's disease. Vol. 2. Florham Park (NJ): Macmillan Health Care Information; 1987. p. 153-164.
14. AJ Hughes SE Daniel L Kilford AJ Lees 1992 Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases J Neurol Neurosurg Psychiatry 55 181 184 1564476 10.1136/jnnp.55.3.181 1:STN:280:DyaK383is1Omsg%3D%3D
15. S Gilman GK Wenning PA Low DJ Brooks CJ Mathias JQ Trojanowski, et al. 2008 Second consensus statement on the diagnosis of multiple system atrophy Neurology 71 9 670 676 18725592 10.1212/01.wnl.0000324625.00404.15 1:STN:280:DC%2BD1crktlWmsA%3D%3D
16. JT Kuikka KA Bergstrom A Ahonen E Lansimies 1994 The dosimetry of iodine-123 labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane Eur J Nucl Med 21 53 56 8088286 1:CAS:528:DyaK2cXlsFaiurc%3D
17. M Laruelle E Wallace JP Seibyl RM Baldwin Y Zea-Ponce SS Zoghbi, et al. 1994 Graphical, kinetic, and equilibrium analyses of in vivo [123I]beta-CIT binding to dopamine transporters in healthy human subjects J Cereb Blood Flow Metab 14 982 994 7929662 10.1038/jcbfm.1994.131 1:CAS:528:DyaK2MXitFGisro%3D
18. RB Innis VJ Cunningham J Delforge M Fujita A Gjedde RN Gunn, et al. 2007 Consensus nomenclature for in vivo imaging of reversibly binding radioligands J Cereb Blood Flow Metab 27 1533 1539 17519979 10.1038/sj.jcbfm.9600493 1:CAS:528:DC%2BD2sXptlSqtrc%3D
19. J De Keyser JP De Backer G Ebinger G Vauquelin 1989 [3H]GBR 12935 binding to dopamine uptake sites in the human brain J Neurochem 53 1400 1404 2795007 10.1111/j.1471-4159.1989.tb08530.x
20. C Rorden M Brett 2000 Stereotaxic display of brain lesions Behav Neurol 12 191 200 11568431
21. KJ Friston J Ashburner CD Frith JB Poline JD Heather RS Frackowiak 1995 Spatial registration and normalization of images Hum Brain Mapp 2 165 189 10.1002/hbm.460030303
22. JS Rakshi T Uema K Ito DL Bailey PK Morrish J Ashburner, et al. 1999 Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease. A 3D [(18)F]dopa-PET study Brain 122 Pt 9 1637 1650 10468504 10.1093/brain/122.9.1637
23. KJ Worsley S Marrett P Neelin AC Vandal KJ Friston AC Evans 1996 A unified statistical approach for determining significant signals in images of cerebral activation Hum Brain Mapp 4 58 73 20408186 10.1002/(SICI)1097- 0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O 1:STN:280:DC%2BC3c3nslKisw%3D%3D
24. A Antonini R Benti R De Notaris S Tesei A Zecchinelli G Sacilotto, et al. 2003 123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy Neurol Sci 24 149 150 14598060 10.1007/s10072-003-0103-5 1:STN:280:DC%2BD3srhvF2qsg%3D%3D
25. W Pirker S Djamshidian S Asenbaum W Gerschlager G Tribl M Hoffmann, et al. 2002 Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study Mov Disord 17 45 53 11835438 10.1002/mds.1265
26. C Scherfler M Nocker 2009 Dopamine transporter SPECT: how to remove subjectivity? Mov Disord 24 Suppl 2 S721 S724 19877234 10.1002/mds.22590
27. YJ Kim M Ichise JR Ballinger D Vines SS Erami T Tatschida, et al. 2002 Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP Mov Disord 17 303 312 11921116 10.1002/mds.10042
28. DJ Brooks EP Salmon CJ Mathias N Quinn KL Leenders R Bannister, et al. 1990 The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET Brain 1990 1539 1552 10.1093/brain/113.5.1539
29. A Kume A Takahashi Y Hashizume 1993 Neuronal cell loss of the striatonigral system in multiple system atrophy J Neurol Sci 117 33 40 8410064 10.1016/0022-510X(93)90151-N 1:STN:280:DyaK2c%2FhsFWmsw%3D%3D
30. PK Morrish GV Sawle DJ Brooks 1996 The rate of progression of Parkinson's disease. A longitudinal [18F]DOPA PET study Adv Neurol 69 427 431 8615162 1:STN:280:DyaK287ptFKrsA%3D%3D
31. Parkinson Study Group 2002 Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression JAMA 287 13 1653 1661 10.1001/jama.287.13.1653
32. JP Seibyl K Marek K Sheff RM Baldwin S Zoghbi Y Zea-Ponce, et al. 1997 Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients J Nucl Med 38 1453 1459 9293807 1:CAS:528:DyaK2sXmt1Sksr0%3D
33. J Booij JB Habraken P Bergmans G Tissingh A Winogrodzka EC Wolters, et al. 1998 Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease J Nucl Med 39 1879 1884 9829575 1:CAS:528:DyaK1cXnsFWjsLY%3D
34. PK Morrish 2003 How valid is dopamine transporter imaging as a surrogate marker in research trials in Parkinson's disease Mov Disord 18 Suppl 7 S63 S70 14531048 10.1002/mds.10581
35. K Seppi C Scherfler E Donnemiller I Virgolini MF Schocke G Goebel, et al. 2006 Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysis Arch Neurol 63 1154 1160 16908744 10.1001/archneur.63.8.1154
36. R Innis R Baldwin E Sybirska Y Zea M Laruelle M al-Tikriti, et al. 1991 Single photon emission computed tomography imaging of monoamine reuptake sites in primate brain with [123I]CIT Eur J Pharmacol 200 369 370 1782997 10.1016/0014-2999(91)90599-L 1:CAS:528:DyaK3MXmsFWisbY%3D
37. JK Staley M Basile DD Flynn DC Mash 1994 Visualizing dopamine and serotonin transporters in the human brain with the potent cocaine analogue [125I]RTI-55: in vitro binding and autoradiographic characterization J Neurochem 62 549 556 8294917 10.1046/j.1471-4159.1994.62020549.x 1:CAS:528: DyaK2cXht1Grtbk%3D
38. W Pirker S Asenbaum S Kasper H Walter P Angelberger G Koch, et al. 1995 beta-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo J Neural Transm Gen Sect 100 247 256 8748670 10.1007/BF01276462 1:CAS:528:DyaK2MXosVehs74%3D
39. GR Uhl 1992 Neurotransmitter transporters (plus): a promising new gene family Trends Neurosci 15 265 268 1381123 10.1016/0166-2236(92)90068-J 1:CAS:528:DyaK38XlsVCnsrg%3D
40. GK Wenning C Colosimo F Geser W Poewe 2004 Multiple system atrophy Lancet Neurol 3 93 103 14747001 10.1016/S1474-4422(03)00662-8
41. MI Papp PL Lantos 1994 The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology Brain 117 Pt 2 235 243 8186951 10.1093/brain/117.2.235
42. EE Benarroch AM Schmeichel PA Low JE Parisi 2004 Involvement of medullary serotonergic groups in multiple system atrophy Ann Neurol 55 418 422 14991820 10.1002/ana.20021
43. G Glover N Pelc 1979 The nonlinear partial volume artefact J Comput Assist Tomogr 25 79 86
44. EJ Hoffman SC Huang ME Phelps 1979 Quantification in positron emission tomography. 1. Effect of object size J Comput Assist Tomogr 22 324 333
45. A Kojima M Matsumoto M Takahashi Y Hirota H Yoshida 1989 Effect of spatial resolution on SPECT quantification values J Nucl Med 30 508 514 2786945 1:STN:280:DyaL1M3ptlaqtA%3D%3D
46. W Pirker I Holler W Gerschlager S Asenbaum G Zettinig T Brucke 2003 Measuring the rate of progression of Parkinson's disease over a 5-year period with beta-CIT SPECT Mov Disord 18 1266 1272 14639666 10.1002/mds.10531
47. J Muller GK Wenning K Jellinger A McKee W Poewe I Litvan 2000 Progression of Hoehn and Yahr stages in Parkinsonian disorders: a clinicopathologic study Neurology 55 888 891 10994019 1:STN:280:DC%2BD3M%2FgvVClug%3D%3D
48. J Jankovic M McDermott J Carter S Gauthier C Goetz L Golbe, et al. 1990 Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group Neurology 40 1529 1534 2215943 1:STN:280:DyaK3M%2FhsFOltQ%3D%3D